Jonathan G Pol (Jonathan Pol)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 37

Top Venues

Oncoimmunology

Cancers

Gut

Journal for immunotherapy of cancer

Centre de Recherches BioMédicales des Cordeliers

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre de Recherches BioMédicales des Cordeliers

France

Postdoctoral researcher :: INSERM U1138

McMaster University

Canada

Postdoctoral researcher :: McMaster Immunology Research Centre (MIRC) - Department of Pathology and Molecular Medicine

Hôpital universitaire Necker-Enfants malades

France

PhD candidate :: INSERM U370 - U812 - U845

Institut Pasteur

France

PhD candidate :: INSERM U370 - U812 - U845

Publications

Luca Fabris, Jonathan G Pol
Mast cells and histamine in cholangiocarcinoma: exploring overlooked avenues for enhanced patient management. Gut (2024)
Manuela Lizarralde-Guerrero, Laura Zucaro, Guido Kroemer, Jonathan G Pol
Single-cell analysis of T lymphocytes infiltrating colorectal carcinoma: the dilemma of specificity. Oncoimmunology 13 (1) (2024)
Jonathan G Pol, Manuela Lizarralde-Guerrero, Andrea Checcoli, Guido Kroemer
Targeted opening of the blood-brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma. Oncoimmunology 13 (1) (2024)
Manuela Lizarralde-Guerrero, Laura Zucaro, Guido Kroemer, Jonathan G Pol
Single-cell analysis of T lymphocytes infiltrating colorectal carcinoma: the dilemma of specificity. Oncoimmunology 13 (1) (2024)
Luca Fabris, Jonathan G Pol
Mast cells and histamine in cholangiocarcinoma: exploring overlooked avenues for enhanced patient management. Gut 73 (8) (2024)
Luca Fabris, Jonathan G Pol
Mast cells and histamine in cholangiocarcinoma: exploring overlooked avenues for enhanced patient management. Gut 73 (8) (2024)
Jonathan G Pol, Manuela Lizarralde-Guerrero, Guido Kroemer
Immunogenic oncolysis by tigilanol tiglate. Oncoimmunology 13 (1) (2024)
Jonathan G Pol, Manuela Lizarralde-Guerrero, Andrea Checcoli, Guido Kroemer
Targeted opening of the blood-brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma. Oncoimmunology 13 (1) (2024)
Jonathan G Pol, Manuela Lizarralde-Guerrero, Andrea Checcoli, Guido Kroemer
Targeted opening of the blood-brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma. Oncoimmunology 13 (1) (2024)
Jonathan G Pol, Manuela Lizarralde-Guerrero, Guido Kroemer
Immunogenic oncolysis by tigilanol tiglate. Oncoimmunology 13 (1) (2024)
Luca Fabris, Jonathan G Pol
Mast cells and histamine in cholangiocarcinoma: exploring overlooked avenues for enhanced patient management. Gut (2024)
Shuai Zhang, Liwei Zhao, Mengfei Guo, Peng Liu, Sijing Li, Wei Xie, Ai-Ling Tian, Jonathan G Pol, Hui Chen, Hui Pan, Misha Mao, Yumei Li, Laurence Zitvogel, Yang Jin, Oliver Kepp, Guido Kroemer
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses. Journal for immunotherapy of cancer 11 (7) (2023)
Maria Perez-Lanzon, Vincent Carbonnier, Pierre Cordier, Fatima Domenica Elisa De Palma, Adriana Petrazzuolo, Christophe Klein, Floriane Arbaretaz, Khady Mangane, Gautier Stoll, Isabelle Martins, Helene Fohrer Ting, Juliette Paillet, Sophie Mouillet-Richard, Delphine Le Corre, Wenjjin Xiao, Marine Sroussi, Chantal Desdouets, Pierre Laurent-Puig, Jonathan G Pol, Carlos Lopez-Otin, Maria Chiara Maiuri, Guido Kroemer
New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma. Journal for immunotherapy of cancer 11 (6) (2023)
Fatima Domenica Elisa De Palma, Vincent Carbonnier, Francesco Salvatore, Guido Kroemer, Jonathan G Pol, Maria Chiara Maiuri
Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human Cancers. Cancers 14 (23) (2022)
Jonathan G Pol, Céleste Plantureux, Maria Perez-Lanzon, Guido Kroemer
PDIA3 as a potential bridge between immunogenic cell death and autoreactivity. Oncoimmunology 11 (1) (2022)
Fatima Domenica Elisa De Palma, Francesco Salvatore, Jonathan G Pol, Guido Kroemer, Maria Chiara Maiuri
Circular RNAs as Potential Biomarkers in Breast Cancer. Biomedicines 10 (3) (2022)
Pan Juncheng, Adrien Joseph, Antoine Lafarge, Isabelle Martins, Florine Obrist, Jonathan G Pol, Ester Saavedra, Sijing Li, Allan Sauvat, Giulia Cerrato, Sarah Lévesque, Marion Leduc, Oliver Kepp, Sylvère Durand, Fanny Aprahamian, Nitharsshini Nirmalathansan, Judith Michels, Guido Kroemer, Maria Castedo
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer. Journal for immunotherapy of cancer 10 (6) (2022)
Fatima Domenica Elisa De Palma, Vincent Carbonnier, Francesco Salvatore, Guido Kroemer, Jonathan G Pol, Maria Chiara Maiuri
Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human Cancers. Cancers 14 (23) (2022)
Fatima Domenica Elisa De Palma, Vincent Carbonnier, Francesco Salvatore, Guido Kroemer, Jonathan G Pol, Maria Chiara Maiuri
Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human Cancers. Cancers 14 (23) (2022)
Jonathan G Pol, Juliette Paillet, Céleste Plantureux, Guido Kroemer
Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseases. Oncoimmunology 11 (1) (2022)
Lucillia Bezu, Alejandra Wu Chuang, Allan Sauvat, Juliette Humeau, Wei Xie, Giulia Cerrato, Peng Liu, Liwei Zhao, Shuai Zhang, Julie Le Naour, Jonathan G Pol, Peter van Endert, Oliver Kepp, Fabrice Barlesi, Guido Kroemer
Local anesthetics elicit immune-dependent anticancer effects. Journal for immunotherapy of cancer 10 (4) (2022)
Dina Kremsdorf, Bouchra Lekbaby, Pierre Bablon, Jules Sotty, Jérémy Augustin, Aurélie Schnuriger, Jonathan G Pol, Patrick Soussan
Alternative splicing of viral transcripts: the dark side of HBV. Gut 70 (12) (2021)
Jonathan G Pol, Juliette Paillet, Céleste Plantureux, Guido Kroemer
Beneficial autoimmunity links primary biliary cholangitis to the avoidance of cholangiocarcinoma. Oncoimmunology 10 (1) (2021)
Erwan Eriau, Juliette Paillet, Guido Kroemer, Jonathan G Pol
Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy. Cancers 13 (6) (2021)
Juliette Paillet, Céleste Plantureux, Sarah Lévesque, Julie Le Naour, Gautier Stoll, Allan Sauvat, Pamela Caudana, Jimena Tosello, Norma Bloy, Sylvie Lachkar, Isabelle Martins, Paule Opolon, Andrea Checcoli, Agathe Delaune, Noémie Robil, Pierre de la Grange, Juliette Hamroune, Franck Letourneur, Gwennhael Autret, Patrick S C Leung, Merrill Eric Gershwin, Jie S Zhu, Mark J Kurth, Bouchra Lekbaby, Jérémy Augustin, Youra Kim, Shashi Gujar, Cédric Coulouarn, Laura Fouassier, Laurence Zitvogel, Eliane Piaggio, Chantal Housset, Patrick Soussan, Maria Chiara Maiuri, Guido Kroemer, Jonathan G Pol
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma. The Journal of experimental medicine 218 (10) (2021)
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer, Jonathan G Pol
Trial watch: intratumoral immunotherapy. Oncoimmunology 10 (1) (2021)
Jonathan G Pol, Matthew J Atherton, Kyle B Stephenson, Byram W Bridle, Samuel T Workenhe, Natasha Kazdhan, Aj Robert McGray, Yonghong Wan, Guido Kroemer, Brian D Lichty
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning. Journal for immunotherapy of cancer 8 (2) (2021)
Juliette Humeau, Allan Sauvat, Giulia Cerrato, Wei Xie, Friedemann Loos, Francesca Iannantuoni, Lucillia Bezu, Sarah Lévesque, Juliette Paillet, Jonathan G Pol, Marion Leduc, Laurence Zitvogel, Hugues de Thé, Oliver Kepp, Guido Kroemer
Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress. EMBO molecular medicine 12 (5) (2020)
Adrien Joseph, Stéphanie Moriceau, Valentina Sica, Gerasimos Anagnostopoulos, Jonathan G Pol, Isabelle Martins, Antoine Lafarge, Maria Chiara Maiuri, Marion Leboyer, Josephine Loftus, Frank Bellivier, Raoul Belzeaux, Fabrice Berna, Bruno Etain, Delphine Capdevielle, Philippe Courtet, Caroline Dubertret, Julien Dubreucq, D' Amato Thierry, Guillaume Fond, Sebastien Gard, Pierre-Michel Llorca, Jasmina Mallet, David Misdrahi, Emilie Olié, Christine Passerieux, Mircea Polosan, Paul Roux, Ludovic Samalin, Franck Schürhoff, Raymond Schwan, null null, Christophe Magnan, Franck Oury, José M Bravo-San Pedro, Guido Kroemer
Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI). Cell death & disease 11 (7) (2020)
Francesca Castoldi, Juliette Humeau, Isabelle Martins, Sylvie Lachkar, Damarys Loew, Florent Dingli, Sylvère Durand, David Enot, Noëlie Bossut, Alexis Chery, Fanny Aprahamian, Yohann Demont, Paule Opolon, Nicolas Signolle, Allan Sauvat, Michaela Semeraro, Lucillia Bezu, Elisa Elena Baracco, Erika Vacchelli, Jonathan G Pol, Sarah Lévesque, Norma Bloy, Valentina Sica, Maria Chiara Maiuri, Guido Kroemer, Federico Pietrocola
Autophagy-mediated metabolic effects of aspirin. Cell death discovery 6 (1) (2020)
Jonathan G Pol, Julie Le Naour, Guido Kroemer
FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin. Oncoimmunology 9 (1) (2020)
Julie Le Naour, Peng Liu, Liwei Zhao, Sandy Adjemian, Zsofia Sztupinszki, Julien Taieb, Claire Mulot, Aymeric Silvin, Charles-Antoine Dutertre, Florent Ginhoux, Allan Sauvat, Giulia Cerrato, Francesca Castoldi, Isabelle Martins, Gautier Stoll, Juliette Paillet, Khady Mangane, Cornelia Richter, Oliver Kepp, Maria Chiara Maiuri, Federico Pietrocola, Peter Vandenabeele, Fabrice Andre, Suzette Delaloge, Zoltan Szallasi, Pierre Laurent-Puig, Jessica Zucman-Rossi, Laurence Zitvogel, Jonathan G Pol, Erika Vacchelli, Guido Kroemer
A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency. Cancer discovery 11 (2) (2020)
Sarah Lévesque, Julie Le Naour, Federico Pietrocola, Juliette Paillet, Margerie Kremer, Francesca Castoldi, Elisa E Baracco, Yan Wang, Erika Vacchelli, Gautier Stoll, Ariane Jolly, Pierre De La Grange, Laurence Zitvogel, Guido Kroemer, Jonathan G Pol
A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice. Oncoimmunology 8 (11) (2019)
Fatima Domenica Elisa De Palma, Valeria DArgenio, Jonathan G Pol, Guido Kroemer, Maria Chiara Maiuri, Francesco Salvatore
The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer. Cancers 11 (7) (2019)
Florine Obrist, Judith Michels, Sylvere Durand, Alexis Chery, Jonathan G Pol, Sarah Levesque, Adrien Joseph, Valentina Astesana, Federico Pietrocola, Gen Sheng Wu, Maria Castedo, Guido Kroemer
Metabolic vulnerability of cisplatin-resistant cancers. The EMBO journal 37 (14) (2018)
Jonathan G Pol, Sergio A Acuna, Beta Yadollahi, Nan Tang, Kyle B Stephenson, Matthew J Atherton, David Hanwell, Alexander El-Warrak, Alyssa Goldstein, Badru Moloo, Patricia V Turner, Roberto Lopez, Sandra LaFrance, Carole Evelegh, Galina Denisova, Robin Parsons, Jamie Millar, Gautier Stoll, Chantal G Martin, Julia Pomoransky, Caroline J Breitbach, Jonathan L Bramson, John C Bell, Yonghong Wan, David F Stojdl, Brian Dennis Lichty, J Andrea McCart
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials. Oncoimmunology 8 (1) (2018)
Byram W Bridle, Andrew Nguyen, Omar Salem, Liang Zhang, Sandeep T Koshy, Derek Clouthier, Lan Chen, Jonathan G Pol, Stephanie Louise Swift, Dawn M E Bowdish, Brian D Lichty, Jonathan L Bramson, Yonghong Wan
Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination. Journal of immunology (Baltimore, Md. : 1950) 196 (11) (2016)

Jonathan G Pol.css-eqlu8i{font-size:small;padding-left:4px;} (Jonathan Pol)

Publication Activity (10 Years)

Top Topics

Top Venues

Jonathan G Pol (Jonathan Pol)